Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | STAT1 | P42224 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | DHODH | Q02127 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL522838 | 0.84 | ALDH1A1 (0.57) | ALDH1A1TDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL25087359 | 0.83 | ALDH1A1 (0.53) | ALDH1A1TDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL6833259 | 0.82 | TDP1 (0.67) | ALDH1A1TDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL30637112 | 0.82 | ALDH1A1 (0.46) | ALDH1A1TDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL23182973 | 0.82 | KMT2A (0.55) | ALDH1A1TDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL8839214 | 0.82 | ALDH1A1 (0.67) | ALDH1A1TDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL21755163 | 0.81 | ALDH1A1 (0.54) | ALDH1A1TDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL31371501 | 0.80 | FFAR4 (0.58) | ALDH1A1TDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL6133440 | 0.80 | FFAR4 (0.58) | ALDH1A1TDP1KMT2ASLC6A2SLC6A3 | |
| SCHEMBL21007975 | 0.79 | TDP1 (0.67) | ALDH1A1TDP1KMT2ASLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11091504-B2 | Process for the preparation of tavaborole, its novel polymorphic forms and the polymorphs thereof | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) | 2021-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11091504-B2 | Process for the preparation of tavaborole, its novel polymorphic forms and the polymorphs thereof | HLA-B, VKORC1L1, VPS4B | ALDH1A1 1902/4885TDP1 1378/4885KMT2A 3993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.